Understanding the intricacies of biopharmaceutical science is paramount for developing effective processes in both clinical and commercial manufacturing. By attending this course, you will gain an understanding of the critical manufacturing operations, including cell culture and fermentation, harvest and recovery, viral removal and inactivation, and purification processes like tangential flow filtration, centrifugation, size exclusion, and adsorptive chromatography.
What You Will Learn:
Over two intensive days, you'll gain a comprehensive understanding of biotech manufacturing processes, including a comparison with small molecules. Our curriculum covers the underlying principles of proteins and cells, providing a solid foundation for understanding therapeutic protein manufacturing.
Key topics include:
2-Day Course Modules
Resources and Activities
Who Should Attend?
A buffet lunch and refreshments will be provided each day. The price also includes 1 night’s accommodation, dinner, bed and breakfast.
ISPE Membern> £ 950
Emerging Leader ISPE Member £ 750
ISPE Non-Member £ 1,500
Emerging Leader ISPE Non-Member £ 1,200
All delegates will receive an electronic copy of the ISPE Guide: Biopharmaceutical Process Development and Manufacturing.
Price includes one year’s ISPE membership for non-members.
To reserve your place on the course please email the following details to NorthEast@ispeuk.org
Dr. Peter Dodd, an approved ISPE trainer, commenced his career in Chemical Engineering at ICI Billingham, where he served as the last Fermentation Engineer overseeing the world's largest fermenter, which operated continuously for months necessitating meticulous sterile engineering. He played a pivotal role in pioneering the world's first continuous GMO product and served as a technical leader in the manufacture of microbial and plant-based bioplastics. Notably, he spearheaded the startup of Fujifilm Diosynth's commercial-scale microbial biopharmaceutical facility and held various key positions such as Head of Manufacturing, Head of Commercial QA, and Site Director for Fujifilm's Billingham site.
His expertise extends to Business Development, Mammalian Plant Qualification, and extensive experience as Gold Command for Site Emergencies. Predominantly, he focused on process development, successfully scaling up and transferring numerous biopharmaceutical processes. Post-retirement, he facilitated the tech transfer of the AstraZeneca Covid-19 vaccine to a different continent and played a crucial role in ISPE UK's Covid-19 response efforts.
Peter has been an active member of ISPE for over two decades, serving as the UK Affiliate Chair from 2015 to 2017 and as Co-Chair from 2022 to 2024. Leveraging his wealth of experience, gained over 32 years at Fujifilm's Billingham site, he has embraced the role of ISPE UK Affiliate's training coordinator, dedicated to imparting his pharmaceutical expertise to the next generation.